Superworth

Rapid Micro Biosystems EPS RPID

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Last 12 months, to Jun 30, 2026
−$1.12
Latest quarter, Q2 FY26
−$0.27
Fiscal year 2025
−$1.07

Rapid Micro Biosystems' earnings per share was −$1.12 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.27.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.07n/a
FY2024−$1.08n/a
FY2023−$1.22n/a
FY2022−$1.43n/a
FY2021−$58.96n/a
FY2020−$125.88n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.27n/a−$1.12
Q1 FY26−$0.31n/a−$1.12
Q4 FY25−$0.28n/a−$1.07
Q3 FY25−$0.26n/a−$1.01
Q2 FY25−$0.27n/a−$1.01
Q1 FY25−$0.26n/a−$1.03
Q4 FY24−$0.22n/a−$1.08
Q3 FY24−$0.26n/a−$1.12
Q2 FY24−$0.29n/a−$1.17
Q1 FY24−$0.31n/a−$1.21
Q4 FY23−$0.26n/a−$1.22
Q3 FY23−$0.31n/a−$1.35

Against its peers

Companies in Healthcare nearest Rapid Micro Biosystems' size, closest first, today.

CompanyEPS, 12 monthsGrowth
RPIDRapid Micro Biosystems−$1.12
NEPHNephros$0.16+33% a year
ATNMActinium Pharmaceuticals$0.36
APTAlpha Pro Tech$0.41+24% a year
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
ICCCImmucell$0.08−58% a year
KEQUKewaunee Scientific$2.76−33% a year
PDEXPro DEX$4.11+52% a year
PLXProtalix BioTherapeutics$0.23+283% a year
NATRNatures Sunshine Products$1.01+36% a year
Peer median$0.38

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Rapid Micro Biosystems

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.